Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2003

Peracetic acid-ethanol treatment of allogeneic avital bone tissue transplants--areliable sterilization method.

Axel Pruss, Ulf B Gobel, Georg Pauli, Moujahed Kao, Michael Seibold, Hans Joachim Monig, Arne Hansen, Rüdiger von Versen

Ann Transplant 2003; 8(2): 34-42 :: ID: 142805

Abstract

OBJECTIVES: Based on the European Standard EN 1040, the validation guidelinesof the German Federal Institute for Drugs and Medical Devices and CPMP guidelines we tested the antimicrobialeffectiveness of a peracetic acid-ethanol sterilization procedure (PES) in allogenic avital bone transplants.STUDY DESIGN: Delipidated human bone spongiosa cubes (15 x 15 x 15 mm) served as tissue. Three envelopedviruses (human immunodeficiency virus type 2, pseudorabies virus, bovine virus diarrhoea virus) and threenon-enveloped viruses (hepatitis A virus, poliovirus, porcine parvovirus) were used. The reduction ofvirus infectivity was measured as TCID50/ml in neutralized supernatants and bone homogenates. Staphylococcusaureus. Enterococcus faecium, Pseudomonas aeruginosa. Bacillus subtilis. Clostridium sporogenes, Mycobacteriumterrae. Candida albicans, Aspergillus niger as well as spores of Bacillus subtilis were tested additionally.PES led to a reduction of virus titres by more than 4 log10. Only HAV showed a reduction below 4 log10(2.87) with residual infectivity. After including a delipidating step for HAV-infected cells, a reductionof over 7 log10 HAV titre was found. For viable bacteria, fungi and spores a titre reduction below thedetection level (5 log10) was achieved after an incubation time of 2 hours. CONCLUSIONS: The peraceticacid-ethanol procedure proved to be a reliable method for the sterilization of human bone transplants(layer thickness < or = 15 mm). However, additional safety measures (anamnestic informations, infectiousserology, HIV-/HBV-/HCV-PCR in case of multiorgan donors) should be taken.

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358